By Stephen Nakrosis Biopharmaceutical company Bionomics Ltd. filed for an initial public offering with the U.S. Securities and Exchange Commission on Monday. The company's shares currently...
Approximately A$20-A$22 million1 total funding to progress BNC210 development for the treatment of PTSD and other anxiety and stress-related disorders (subject to shareholder and FIRB approvals;...
Bionomics Limited (ASX: BNO, OTCQB:BNOEF), a global, clinical stage biopharmaceutical company, today announced that a paper describing the pharmacology of BNC375, a novel positive allosteric...
Bionomics Limited (ASX:BNO, OTCQB:BNOEF), a global, clinical stage biopharmaceutical company leveraging proprietary platform technologies to discover and develop a deep pipeline of novel drug...
Bionomics Limited (ASX:BNO, OTCQX:BNOEF), a global, clinical stage biopharmaceutical company discovering and developing a pipeline of novel drug candidates targeting ion channels, announced...
Additional work undertaken on a drug exposure-response analysis shows a statistically significant response of BNC210 in treatment of PTSD symptoms, as measured by CAPS-5 at 12 weeks...
Bionomics and Merck Enter New Research Collaboration Agreement to fund development of compounds for cognitive impairment associated with Alzheimer's disease and other conditions of the central...
Saabira Chaudhuri Bionomics Ltd. (BNO.AU) has struck a deal of up to $172 million with Merck & Co. (MRK) to discover and develop novel small molecule candidates for the treatment of chronic...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
156 | -0.105 | -91.3043478261 | 0.115 | 0.14 | 0.009 | 1157540 | 0.03954936 | DE |
260 | -0.09 | -90 | 0.1 | 0.485 | 0.009 | 1033692 | 0.09876735 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.